Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid “over”- and “under”-diagnosis of CKD

Kidney International

Volumn 89, Issue 6, 2016, Pages 1363-1371

  Benghanem Gharbi, Mohammed ^a   Elseviers, Monique ^b   Zamd, Mohamed ^a   Belghiti Alaoui, Abdelali ^c   Benahadi, Naïma ^c   Trabelssi, El Hassane ^c   Bayahia, Rabia ^d   Ramdani, Benyounès ^a   De Broe, Marc E ^b  

^a HASSAN II UNIVERSITY   (Morocco)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c Ministry of Health Morocco   (Morocco)

^d MOHAMMED V UNIVERSITY   (Morocco)

Author keywords

chronic kidney disease; diabetes; hypertension; Morocco; obesity; overdiagnosis of CKD; underdiagnosis of CKD

Indexed keywords

CREATININE; GLUCOSE; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY WEIGHT; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEMATURIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MOROCCO; OBESITY; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROTEINURIA; SEX RATIO; AGE; ANALYSIS; ARAB; BLOOD; CROSS-SECTIONAL STUDY; MIDDLE AGED; PREVALENCE; RANDOMIZATION; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; SEX DIFFERENCE; URINE;

ADULT; AGE FACTORS; AGED; ARABS; BLOOD GLUCOSE; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; GLOMERULAR FILTRATION RATE; HEMATURIA; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MOROCCO; OBESITY; PREVALENCE; PROTEINURIA; RANDOM ALLOCATION; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SEX FACTORS;

EID: 84978138751     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.02.019     Document Type: Article

References (40)

1. 1 Eckardt, K.U., Coresh, J., Devuyst, O., et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 382 (2013), 158–169.
2. 2 Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int(suppl 3), 2013, 1–150.
3. 3 Luyckx, V.A., Naicker, S., McKee, M., Equity and economics of kidney disease in sub-Saharan Africa. Lancet 382 (2013), 103–104.
4. 4 Naicker, S., Burden of end-stage renal disease in sub-Saharan Africa. Clin Nephrol 74:suppl 1 (2010), S13–S16.
5. 5 McCullough, K., Sharma, P., Ali, T., et al. Measuring the population burden of chronic kidney disease: a systematic literature review of the estimated prevalence of impaired kidney function. Nephrol Dial Transplant 27 (2012), 1812–1821.
6. 6 Brück, K., Jager, K.J., Dounousi, E., et al. Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review. Nephrol Dial Transplant 30:suppl 4 (2015), iv6–iv16.
7. 7 Zhang, Q.L., Rothenbacher, D., Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health, 8, 2008, 117.
8. 8 Anothaisintawee, T., Rattanasiri, S., Ingsathit, A., et al. Prevalence of chronic kidney disease: a systematic review and meta-analysis. Clin Nephrol 71 (2009), 244–254.
9. 9 Zhang, L., Wang, F., Wang, L., et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379 (2012), 815–822.
10. 10 Hallan, S.I., Coresh, J., Astor, B.C., et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 17 (2006), 2275–2284.
11. 11 Coresh, J., Selvin, E., Stevens, L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007), 2038–2047.
12. 12 Wen, C.P., Cheng, T.Y., Tsai, M.K., et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 371 (2008), 2173–2182.
13. 13 Perkovic, V., Cass, A., Patel, A.A., et al., for the InterASIA Collaborative Group. High prevalence of chronic kidney disease in Thailand. Kidney Int 73 (2008), 473–479.
14. 14 Hooi, L.S., Ong, L.M., Ahmad, G., et al. A population-based study measuring the prevalence of chronic kidney disease among adults in West Malaysia. Kidney Int 84 (2013), 1034–1040.
15. 15 Mills, K.T., Xu, Y., Zhang, W., et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int 88 (2015), 950–957.
16. 16 Myers, G.L., Miller, W.G., Coresh, J., et al., for the National Kidney Disease Education Program Laboratory Working Group. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 52 (2006), 5–18.
17. 17 Levey, A.S., Coresh, J., Greene, T., et al., for the Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145 (2006), 247–254.
18. 18 Qaseem, A., Wilt, T.J., Cooke, M., Denberg, T.D., The paucity of evidence supporting screening for stages 1–3 CKD in asymptomatic patients with or without risk factors. Clin J Am Soc Nephrol 9 (2014), 1993–1995.
19. 19 Pugia, M.J., Wallace, J.F., Lott, J.A., et al. Albuminuria and proteinuria in hospitalized patients as measured by quantitative and dipstick methods. J Clin Lab Anal 15 (2001), 295–300.
20. 20 Glassock, R.J., Is the presence of microalbuminuria a relevant marker of kidney disease?. Curr Hypertens Rep 12 (2010), 364–368.
21. 21 Lin, J., Knight, E.L., Hogan, M.L., Singh, A.K., A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol 14 (2003), 2573–2580.
22. 22 Stevens, L.A., Coresh, J., Greene, T., Levey, A.S., Assessing kidney function–measured and estimated glomerular filtration rate. N Engl J Med 354 (2006), 2473–2483.
23. 23 Eriksen, B.O., Ingebretsen, O.C., In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression. Kidney Int 72 (2007), 1242–1248.
24. 24 Inker, L.A., Tighiouart, H., Aspelund, T., et al. Lifetime risk of stage 3–5 CKD in a community-based sample in Iceland. Clin J Am Soc Nephrol 10 (2015), 1575–1584.
25. 25 Eriksen, B.O., Ingebretsen, O.C., The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 69 (2006), 375–382.
26. 26 Glassock, R.J., Con: thresholds to define chronic kidney disease should not be age dependent. Nephrol Dial Transplant 29 (2014), 774–779.
27. 27 Levey, A.S., Coresh, J., Chronic kidney disease. Lancet 379 (2012), 165–180.
28. 28 Brantsma, A.H., Bakker, S.J., Hillege, H.L., et al., for the PREVEND Study Group. Cardiovascular and renal outcome in subjects with K/DOQI stage 1–3 chronic kidney disease: the importance of urinary albumin excretion. Nephrol Dial Transplant 23 (2008), 3851–3858.
29. 29 O'Hare, A.M., Bertenthal, D., Covinsky, K.E., et al. Mortality risk stratification in chronic kidney disease: one size for all ages?. J Am Soc Nephrol 17 (2006), 846–853.
30. 30 O'Hare, A.M., Measures to define chronic kidney disease. JAMA, 309, 2013, 1343.
31. 31 de Jong, P.E., Gansevoort, R.T., Fact or fiction of the epidemic of chronic kidney disease–let us not squabble about estimated GFR only, but also focus on albuminuria. Nephrol Dial Transplant 23 (2008), 1092–1095.
32. 32 Coresh, J., Byrd-Holt, D., Astor, B.C., et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16 (2005), 180–188.
33. 33 Elseviers, M.M., Verpooten, G.A., De Broe, M.E., De Backer, G.G., Interpretation of creatinine clearance. Lancet, 1, 1987, 457.
34. 34 Wetzels, J.F., Kiemeney, L.A., Swinkels, D.W., et al. Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int 72 (2007), 632–637.
35. 35 Rule, A.D., Gussak, H.M., Pond, G.R., et al. Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis 43 (2004), 112–119.
36. 36 Baba, M., Shimbo, T., Horio, M., et al. Longitudinal study of the decline in renal function in healthy subjects. PLoS One, 10, 2015, e0129036.
37. 37 Zhou, X.J., Rakheja, D., Yu, X., et al. The aging kidney. Kidney Int 74 (2008), 710–720.
38. 38 Tazi, M.A., Abir-Khalil, S., Chaouki, N., et al. Prevalence of the main cardiovascular risk factors in Morocco: results of a National Survey, 2000. J Hypertens 21 (2003), 897–903.
39. 39 Rguibi, M., Belahsen, R., Fattening practices among Moroccan Sahraoui women. East Mediterr Health J 12 (2006), 619–624.
40. 40 Stokholm, K.H., Brøchner-Mortensen, J., Hoilund-Carlsen, P.F., Increased glomerular filtration rate and adrenocortical function in obese women. Int J Obes 4 (1980), 57–63.